CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Tenofovir disoproxil fumarate

Last Updated: August 11, 2005
Result type: Reports
Project Number: SR0040-000
Product Line: Reimbursement Review

Generic Name: Tenofovir disoproxil fumarate

Brand Name: Viread

Manufacturer: Gilead Sciences Canada Inc.

Therapeutic Area: HIV infection

Indications: HIV infection

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: March 15, 2006

Recommendation Type: List with clinical criteria and/or conditions